Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Shufersal Ltd.
  6. Summary
    SAE   IL0007770378

SHUFERSAL LTD.

(SAE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
07/20/2021 07/21/2021 07/22/2021 07/25/2021 07/26/2021 Date
2535(c) 2566(c) 2537(c) 2554(c) 2536(c) Last
1 014 438 564 941 404 578 119 760 314 828 Volume
-0.04% +1.22% -1.13% +0.67% -0.70% Change
More quotes
Estimated financial data (e)
Sales 2021 14 837 M 4 559 M 4 559 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 15 439 M 4 744 M 4 744 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 6 503 M 1 997 M 1 998 M
Capi. / Sales 2021 0,44x
Capi. / Sales 2022 0,42x
Nbr of Employees 16 000
Free-Float 96,8%
More Financials
Company
Shufersal Ltd is engaged in the operation of a chain of supermarkets in Israel. The Company operates through three segments, which include The retail segment, The real estate segment and Credit card customers' club management segment. The Company operates approximately 280 stores across the nation. The retail segment includes the retail marketing of food and other products in the Company's branches, and the... 
Sector
Food Retail & Distribution
Calendar
-
More about the company
All news about SHUFERSAL LTD.
05/19Shufersal Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
2017SHUFERSAL LTD(TASE : SAE) added to TA-35 Index
CI
2017Shufersal Ltd announced that it expects to receive ILS 140.64 million in fund..
CI
2017Shufersal Ltd signed an agreement to acquire New-Pharm Drugstores Ltd. from H..
CI
2017Shufersal In Advanced Talks To Acquire New-Pharm
CI
2017Shufersal Announces Earning Results for the Fourth Quarter of 2016
CI
2017Shufersal In Talks For Possible Acquisition Of New-Pharm Drugstores
CI
2017Shufersal Mulls Acquisition Of New-Pharm
CI
2016An unknown buyer acquired 2% stake in Shufersal Ltd from Matthew Bronfman and..
CI
2016Shufersal Ltd Reports Earnings Results for the Third Quarter of 2016
CI
2016Shufersal Ltd. Reports Earnings Results for the Second Quarter and Six Months..
CI
2016Shufersal Ltd Announces Earnings Results for the First Quarter of 2016
CI
More news
News in other languages on SHUFERSAL LTD.

- No features available -

More news
Chart SHUFERSAL LTD.
Duration : Period :
Shufersal Ltd. Technical Analysis Chart | SAE | IL0007770378 | MarketScreener
Technical analysis trends SHUFERSAL LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 25,36 ILS
Average target price 32,50 ILS
Spread / Average Target 28,2%
Managers and Directors
Itzhak Aberkohen Chief Executive Officer
Talya Huber Chief Financial Officer
Yaki Yacov Vadmani Chairman
Zvi Fishheimer EVP-Human Resources & Information Technology
Sharon Gambasho Vice President-Real Estate, Research & Development
Sector and Competitors
1st jan.Capi. (M$)
SHUFERSAL LTD.2.26%2 089
SEVEN & I HOLDINGS CO., LTD.36.92%40 122
ALIMENTATION COUCHE-TARD INC.14.71%38 193
AVENUE SUPERMARTS LIMITED26.05%28 964
SM INVESTMENTS CORPORATION-9.91%24 699
COLES GROUP LIMITED-2.65%17 061